NCT04239456

Brief Summary

The purpose of this research study is to evaluate the effectiveness of "RehaCom," a computerized treatment for memory deficits, in a 16-session, interactive course. Following a manualized approach, the Rehacom modules will be used for the repeated application of the content acquired during 1-on-1 memory strategy training. The goal is to improve face/name, list and verbal memory of patients who survived a moderate to severe traumatic brain injury.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2018

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

December 17, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 27, 2020

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2022

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

4 years

First QC Date

December 17, 2019

Last Update Submit

March 30, 2022

Conditions

Keywords

TBIFace memoryVerbal MemoryLearningCognitionMemory trainingPilot studycompensatory memory strategiescognitive rehabilitation

Outcome Measures

Primary Outcomes (3)

  • Change in California Verbal Learning Test - II (CVLT-II) performance

    We will use the raw scores for free and cued delayed recall \[0-16\] where higher scores indicate better verbal recall.

    Baseline & 10-14 weeks after baseline assessment

  • Change in the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) - Story Memory performance

    Raw scores from Story A and Story B recall \[0-50\], where higher scores indicate better recall.

    baseline & 10-14 weeks after baseline assessment

  • Change in Wechsler Memory Scale III - Faces II performance

    Delayed Recall Score \[0-48\] where higher scores indicate better recall.

    baseline & 10-14 weeks after baseline assessment

Study Arms (2)

Group A

EXPERIMENTAL

Receive intervention 2 weeks after group assignment.

Device: RehaCom (software)

Group B

OTHER

Wait List - Receive intervention 3 months after initial testing.

Device: RehaCom (software)

Interventions

RehaCom software has gamified, interactive modules that will help participants practice the application of various memory strategies at custom, increasingly more difficult levels. Instructor will also use the software to teach and demonstrate the use of memory strategies with the domains targeted (i.e., list learning, remembering written/verbal information, and memory for names/faces).

Group AGroup B

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to read and speak English fluently at the 5th grade level (for testing; software has multilingual support)
  • Had a TBI at least 1 year ago
  • No history of learning disorders during school years
  • Able to use a personal computer (PC) non-stop for 1 hour without health or visual complaints; able to press keyboard buttons.No history of learning disorders

You may not qualify if:

  • Actively participating in another intervention study
  • Distance to Kessler Foundation East Hanover or West Orange location is more than 20 miles.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kessler Foundation

East Hanover, New Jersey, 07936, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Group assignments will be concealed and assessments and interventions will be conducted by trained staff blinded to each other's findings and data.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is a double-blind randomized clinical trial. Participants will be randomly assigned to a treatment group or wait-list control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2019

First Posted

January 27, 2020

Study Start

December 1, 2018

Primary Completion

November 28, 2022

Study Completion

November 28, 2022

Last Updated

March 31, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Data will not be available at the individual level except for parties identified by the New Jersey Health Foundation (funding agency) and approved/mandated by the Kessler Foundation Institutional Review Board (IRB).

Locations